MSCI Schedules Earnings Call to Review Third Quarter 2024 Results

NEW YORK--(BUSINESS WIRE)-- MSCI Inc. (NYSE: MSCI), a leading provider of critical decision support tools and services for the global investment community, announced today it will release its results for the third quarter 2024 on Tuesday, October 29, 2024, before the market opens. A copy of the earnings release, as well as an earnings presentation and a quarterly update, will be made available on MSCI’s Investor Relations website.

MSCI’s senior management will review the third quarter 2024 results on Tuesday, October 29, 2024, at 11:00 AM Eastern Time. To listen to the live event via webcast, visit the events and presentations section of MSCI’s Investor Relations website, https://ir.msci.com/events-and-presentations, or to join via telephone, dial +1-888-596-4144 conference ID 9979278 within the United States. International callers may dial +1-646-968-2525 conference ID 9979278. The earnings call webcast will include an accompanying slide presentation that can be accessed through MSCI’s Investor Relations website.

An archived replay of the webcast also will be available shortly after the live event on MSCI’s Investor Relations website, https://ir.msci.com/events-and-presentations.

About MSCI Inc.

MSCI is a leading provider of critical decision support tools and services for the global investment community. With over 50 years of expertise in research, data, and technology, we power better investment decisions by enabling clients to understand and analyze key drivers of risk and return and confidently build more effective portfolios. We create industry-leading, research-enhanced solutions that clients use to gain insight into and improve transparency across the investment process.

To learn more, please visit www.msci.com. MSCI#IR

View source version on businesswire.com: https://www.businesswire.com/news/home/20240930692435/en/

MSCI Inc.
Investor Inquiries
[email protected]
Jeremy Ulan +1 646 778 4184

[email protected]
Jisoo Suh +1 917 825 7111

Media Inquiries
[email protected]
Melanie Blanco +1 212 981 1049
Konstantinos Makrygiannis +44 (0)7768 930056
Tina Tan +852 2844 9320

Source: MSCI Inc.

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Metropolitan Issues Statement on Release of 2027-2028 Guidelines, ROD for Colorado River Operations
• Vitruvias Therapeutics, Inc. Issues Nationwide Recall of One Lot of Thyroid Tablets, USP 30 mg Due to Potential Super Potency